Platelet Rich Plasma Market Report: Trends, Forecast and Competitive Analysis
Get it in 2 to 4 weeks by ordering today
The future of the global platelet rich plasma market looks promising with opportunities in orthopedics, cosmetic surgery and dermatology, ophthalmic surgery, neurosurgery, and general surgery applications. The global platelet rich plasma market is expected to grow with a CAGR of 12%-14% from 2020 to 2025. The major drivers for this market are increasing demand for plasma therapy in therapeutic areas, rising geriatric population, and growing sports surgeries.
A total of XX figures / charts and XX tables are provided in this more than 150 pages report to help in your business decisions. Sample figures with some insights are shown below. To learn the scope, benefits, companies researched, and other details of the global platelet rich plasma market report, please download the report brochure.
In this market, pure PRP is the largest product type of platelet rich plasma, whereas orthopedics is the largest application. Growth in various segments of the platelet rich plasma market are given below:
The study includes trends and forecast for the global platelet rich plasma market by product, origin, application, end user, and region as follows:
By Product [Value ($ Million) shipment analysis for 2014 – 2025]:
Pure PRPLeukocyte-Rich PRPLeukocyte-Rich Fibrin PRP
By Origin [Value ($ Million) shipment analysis for 2014 – 2025]:
Autologous PRPAllogeneic PRPHomologous PRP
By Application [Value ($ Million) shipment analysis for 2014 – 2025]:
OrthopedicsCosmetic Surgery and DermatologyOphthalmic SurgeryNeurosurgeryGeneral SurgeryOthers
By End User [Value ($ Million) shipment analysis for 2014 – 2025]:
HospitalsOrthopedic ClinicsDermatology ClinicsOthers
By Region [Value ($ Million) shipment analysis for 2014 – 2025]:
North AmericaUnited StatesCanada MexicoEuropeUnited KingdomGermanyFranceAsia PacificChinaIndiaJapanThe Rest of the WorldBrazil
Some of the platelet rich plasma companies profiled in this report includes Arthrex, Terumo BCT, EmCyte, DePuy Synthes, Zimmer Biomet, Stryker, Glofinn, DR. PRP America, Harvest Technologies, and Adistem.
Lucintel forecasts that pure PRP will remain the largest product segment over the forecast period, as it provides effective results in bone regeneration and is less inflammatory as compared to other products.
Within this market, orthopedics will remain the largest segment by application over the forecast period due to increasing aging population and rising incidence of road accidents.
North America will remain the largest region over the forecast period due to increasing application areas of platelet rich plasma in therapeutics, rising cases of orthopedic disorders, and presence of major players of PRP in the region.
Features of the Global Platelet Rich Plasma Market
Market Size Estimates: Global platelet rich plasma market size estimation in terms of value ($M) shipment.Trend and Forecast Analysis: Market trends (2014-2019) and forecast (2020-2025) by various segments.Segmentation Analysis: Global platelet rich plasma market size by various segments, such as product, origin, application, and end user in terms of value.Regional Analysis: Global platelet rich plasma market breakdown by North America, Europe, Asia Pacific, and Rest of the World.Growth Opportunities: Analysis of growth opportunities in different product, origin, application, end user, and region for the global platelet rich plasma market.Strategic Analysis: This includes M&A, new product development, and competitive landscape of the global platelet rich plasma market.Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
This report answers following key questions
Q.1 What are some of the most promising potential, high-growth opportunities for the global platelet rich plasma market by product (pure PRP, leukocyte-rich PRP, and leukocyte-rich fibrin PRP), origin (autologous PRP, allogeneic PRP, and homologous PRP), application (orthopedics, cosmetic surgery & dermatology, ophthalmic surgery, neurosurgery, general surgery, and others), end user (hospitals, orthopedic clinics, dermatology clinics, and others), and region (North America, Europe, Asia Pacific, and Rest of the World)?
Q.2 Which segments will grow at a faster pace and why?
Q.3 Which region will grow at a faster pace and why?
Q.4 What are the key factors affecting market dynamics? What are the drivers and challenges of the global platelet rich plasma market?
Q.5 What are the business risks and threats to the global platelet rich plasma market?
Q.6 What are the emerging trends in this platelet rich plasma market and the reasons behind them?
Q.7 What are some changing demands of customers in this platelet rich plasma market?
Q.8 What are the new developments in this platelet rich plasma market? Which companies are leading these developments?
Q.9 Who are the major players in this platelet rich plasma market? What strategic initiatives are being implemented by key players for business growth?
Q.10 What are some of the competitive products and processes in this platelet rich plasma market, and how big of a threat do they pose for loss of market share via material or product substitution?
Q.11 What M&A activities did take place in the last five years in the global platelet rich plasma market?
Report Scope
Key Features Description
Base Year for Estimation 2019
Trend Period
(Actual Estimates) 2014-2019
Forecast Period 2020-2025
Pages More than 150
Market Representation / Units Revenue in US $ Million
Report Coverage Market Trends & Forecasts, Competitor Analysis, New Product Development, Company Expansion, Merger, Acquisitions & Joint Venture, and Company Profiling
Market Segments Product (Pure PRP, Leukocyte-Rich PRP, and Leukocyte-Rich Fibrin PRP), Origin (Autologous PRP, Allogeneic PRP, and Homologous PRP), Application (Orthopedics, Cosmetic Surgery & Dermatology, Ophthalmic Surgery, Neurosurgery, General Surgery, and Others), and End User (Hospitals, Orthopedic Clinics, Dermatology Clinics, and Others)
Regional Scope North America (USA, Mexico, and Canada), Europe (United Kingdom, Germany, and France), Asia (China, India, and Japan), and ROW (Brazil)
Customization 10% Customization without Any Additional Cost
The future of the global platelet rich plasma market looks promising with opportunities in orthopedics, cosmetic surgery and dermatology, ophthalmic surgery, neurosurgery, and general surgery applications. The global platelet rich plasma market is expected to grow with a CAGR of 12%-14% from 2020 to 2025. The major drivers for this market are increasing demand for plasma therapy in therapeutic areas, rising geriatric population, and growing sports surgeries.
A total of XX figures / charts and XX tables are provided in this more than 150 pages report to help in your business decisions. Sample figures with some insights are shown below. To learn the scope, benefits, companies researched, and other details of the global platelet rich plasma market report, please download the report brochure.
In this market, pure PRP is the largest product type of platelet rich plasma, whereas orthopedics is the largest application. Growth in various segments of the platelet rich plasma market are given below:
The study includes trends and forecast for the global platelet rich plasma market by product, origin, application, end user, and region as follows:
By Product [Value ($ Million) shipment analysis for 2014 – 2025]:
Pure PRPLeukocyte-Rich PRPLeukocyte-Rich Fibrin PRP
By Origin [Value ($ Million) shipment analysis for 2014 – 2025]:
Autologous PRPAllogeneic PRPHomologous PRP
By Application [Value ($ Million) shipment analysis for 2014 – 2025]:
OrthopedicsCosmetic Surgery and DermatologyOphthalmic SurgeryNeurosurgeryGeneral SurgeryOthers
By End User [Value ($ Million) shipment analysis for 2014 – 2025]:
HospitalsOrthopedic ClinicsDermatology ClinicsOthers
By Region [Value ($ Million) shipment analysis for 2014 – 2025]:
North AmericaUnited StatesCanada MexicoEuropeUnited KingdomGermanyFranceAsia PacificChinaIndiaJapanThe Rest of the WorldBrazil
Some of the platelet rich plasma companies profiled in this report includes Arthrex, Terumo BCT, EmCyte, DePuy Synthes, Zimmer Biomet, Stryker, Glofinn, DR. PRP America, Harvest Technologies, and Adistem.
Lucintel forecasts that pure PRP will remain the largest product segment over the forecast period, as it provides effective results in bone regeneration and is less inflammatory as compared to other products.
Within this market, orthopedics will remain the largest segment by application over the forecast period due to increasing aging population and rising incidence of road accidents.
North America will remain the largest region over the forecast period due to increasing application areas of platelet rich plasma in therapeutics, rising cases of orthopedic disorders, and presence of major players of PRP in the region.
Features of the Global Platelet Rich Plasma Market
Market Size Estimates: Global platelet rich plasma market size estimation in terms of value ($M) shipment.Trend and Forecast Analysis: Market trends (2014-2019) and forecast (2020-2025) by various segments.Segmentation Analysis: Global platelet rich plasma market size by various segments, such as product, origin, application, and end user in terms of value.Regional Analysis: Global platelet rich plasma market breakdown by North America, Europe, Asia Pacific, and Rest of the World.Growth Opportunities: Analysis of growth opportunities in different product, origin, application, end user, and region for the global platelet rich plasma market.Strategic Analysis: This includes M&A, new product development, and competitive landscape of the global platelet rich plasma market.Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
This report answers following key questions
Q.1 What are some of the most promising potential, high-growth opportunities for the global platelet rich plasma market by product (pure PRP, leukocyte-rich PRP, and leukocyte-rich fibrin PRP), origin (autologous PRP, allogeneic PRP, and homologous PRP), application (orthopedics, cosmetic surgery & dermatology, ophthalmic surgery, neurosurgery, general surgery, and others), end user (hospitals, orthopedic clinics, dermatology clinics, and others), and region (North America, Europe, Asia Pacific, and Rest of the World)?
Q.2 Which segments will grow at a faster pace and why?
Q.3 Which region will grow at a faster pace and why?
Q.4 What are the key factors affecting market dynamics? What are the drivers and challenges of the global platelet rich plasma market?
Q.5 What are the business risks and threats to the global platelet rich plasma market?
Q.6 What are the emerging trends in this platelet rich plasma market and the reasons behind them?
Q.7 What are some changing demands of customers in this platelet rich plasma market?
Q.8 What are the new developments in this platelet rich plasma market? Which companies are leading these developments?
Q.9 Who are the major players in this platelet rich plasma market? What strategic initiatives are being implemented by key players for business growth?
Q.10 What are some of the competitive products and processes in this platelet rich plasma market, and how big of a threat do they pose for loss of market share via material or product substitution?
Q.11 What M&A activities did take place in the last five years in the global platelet rich plasma market?
Report Scope
Key Features Description
Base Year for Estimation 2019
Trend Period
(Actual Estimates) 2014-2019
Forecast Period 2020-2025
Pages More than 150
Market Representation / Units Revenue in US $ Million
Report Coverage Market Trends & Forecasts, Competitor Analysis, New Product Development, Company Expansion, Merger, Acquisitions & Joint Venture, and Company Profiling
Market Segments Product (Pure PRP, Leukocyte-Rich PRP, and Leukocyte-Rich Fibrin PRP), Origin (Autologous PRP, Allogeneic PRP, and Homologous PRP), Application (Orthopedics, Cosmetic Surgery & Dermatology, Ophthalmic Surgery, Neurosurgery, General Surgery, and Others), and End User (Hospitals, Orthopedic Clinics, Dermatology Clinics, and Others)
Regional Scope North America (USA, Mexico, and Canada), Europe (United Kingdom, Germany, and France), Asia (China, India, and Japan), and ROW (Brazil)
Customization 10% Customization without Any Additional Cost
1. EXECUTIVE SUMMARY
2. MARKET BACKGROUND AND CLASSIFICATIONS
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. MARKET TRENDS AND FORECAST ANALYSIS FROM 2014 T 2025
3.1: Macroeconomic Trends and Forecast
3.2: Global Platelet Rich Plasma (PRP) Market Trends and Forecast
3.3: Global Platelet Rich Plasma Market by Product
3.3.1: Pure PRP
3.3.2: Leukocyte-Rich PRP
3.3.3: Leukocyte-Rich Fibrin PRP
3.4: Global Platelet Rich Plasma Market by Origin
3.4.1: Autologous PRP
3.4.2: Allogeneic PRP
3.4.3: Homologous PRP
3.5: Global Platelet Rich Plasma Market by Application
3.5.1: Orthopedics
3.5.2: Cosmetic Surgery and Dermatology
3.5.3: Ophthalmic Surgery
3.5.4: Neurosurgery
3.5.5: General Surgery
3.5.6: Others
3.6: Global Platelet Rich Plasma Market by End User
3.6.1: Hospitals
3.6.2: Orthopedic Clinics
3.6.3: Dermatology Clinics
3.6.4: Others
4. MARKET TRENDS AND FORECAST ANALYSIS BY REGION
4.1: Global Platelet Rich Plasma Market by Region
4.2: North American Platelet Rich Plasma Market
4.2.1: Market by Product: Pure PRP, Leukocyte-Rich PRP, and Leukocyte-Rich Fibrin PRP
4.2.2: Market by Origin: Autologous PRP, Allogeneic PRP, and Homologous PRP
4.2.3: Market by Application: Orthopedics, Cosmetic Surgery and Dermatology, Ophthalmic Surgery, Neurosurgery, General Surgery, and Others
4.2.4: Market by End User: Hospitals, Orthopedic Clinics, Dermatology Clinics, and Others
4.2.5: The United States Platelet Rich Plasma Market
4.2.6: The Canadian Platelet Rich Plasma Market
4.2.7: The Mexican Platelet Rich Plasma Market
4.3: European Platelet Rich Plasma Market
4.3.1: Market by Product: Pure PRP, Leukocyte-Rich PRP, and Leukocyte-Rich Fibrin PRP
4.3.2: Market by Autologous PRP, Allogeneic PRP, and Homologous PRP
4.3.3: Market by Application: Orthopedics, Cosmetic Surgery and Dermatology, Ophthalmic Surgery, Neurosurgery, General Surgery, and Others
4.3.3: Market by End User: Hospitals, Orthopedic Clinics, Dermatology Clinics, and Others
4.3.4: The Platelet Rich Plasma Market of United Kingdom
4.3.5: The Spanish Platelet Rich Plasma Market
4.3.6: The German Platelet Rich Plasma Market
4.3.7: The French Platelet Rich Plasma Market
4.4: APAC Platelet Rich Plasma Market
4.4.1: Market by Product: Pure PRP, Leukocyte-Rich PRP, and Leukocyte-Rich Fibrin PRP
4.4.2: Market by Autologous PRP, Allogeneic PRP, and Homologous PRP
4.4.3: Market by Application: Orthopedics, Cosmetic Surgery and Dermatology, Ophthalmic Surgery, Neurosurgery, General Surgery, and Others
4.4.4: Market by End User: Hospitals, Orthopedic Clinics, Dermatology Clinics, and Others
4.4.5: The Chinese Platelet Rich Plasma Market
4.4.6: The Indian Platelet Rich Plasma Market
4.4.7: The Japanese Platelet Rich Plasma Market
4.5: ROW Platelet Rich Plasma Market
4.5.1: Market by Product: Pure PRP, Leukocyte-Rich PRP, and Leukocyte-Rich Fibrin PRP
4.5.2: Market by Autologous PRP, Allogeneic PRP, and Homologous PRP
4.5.3: Market by Application: Orthopedics, Cosmetic Surgery and Dermatology, Ophthalmic Surgery, Neurosurgery, General Surgery, and Others
4.5.4: Market by End User: Hospitals, Orthopedic Clinics, Dermatology Clinics, and Others
4.5.5: Brazilian Platelet Rich Plasma Market
5. COMPETITOR ANALYSIS
5.1: Market Share Analysis
5.2: Product Portfoli Analysis
5.3: Operational Integration
5.4: Geographical Reach
5.5: Porter’s Five Forces Analysis
6. COST STRUCTURE ANALYSIS
6.1: Cost of Goods Sold
6.2: SG&A
6.3: EBITDA Margin
7. GROWTH OPPORTUNITIES AND STRATEGIC ANALYSIS
7.1: Growth Opportunity Analysis
7.1.1: Growth Opportunities for the Global Platelet Rich Plasma Market by Product
7.1.2: Growth Opportunities for the Global Platelet Rich Plasma Market by Origin
7.1.3: Growth Opportunities for the Global Platelet Rich Plasma Market by Application
7.1.4: Growth Opportunities for the Global Platelet Rich Plasma Market by End User
7.1.5: Growth Opportunities for the Global Platelet Rich Plasma Market by Region
7.2: Emerging Trends in the Global Platelet Rich Plasma Market
7.3: Strategic Analysis
7.3.1: New Product Development
7.3.2: Capacity Expansion of the Global Platelet Rich Plasma Market
7.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Platelet Rich Plasma Market
7.3.4: Certification and Licensing
8. COMPANY PROFILES OF LEADING PLAYERS
8.1: Arthrex, Inc.
8.2: Terum BCT, Inc.
8.3: EmCyte Corporation
8.4: DePuy Synthes
8.5: Zimmer Biomet
8.6: Stryker
8.7: Glofinn Oy
8.8: DR. PRP America, LLC
8.9: Harvest Technologies Corporation
8.10: Adistem Ltd.
2. MARKET BACKGROUND AND CLASSIFICATIONS
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. MARKET TRENDS AND FORECAST ANALYSIS FROM 2014 T 2025
3.1: Macroeconomic Trends and Forecast
3.2: Global Platelet Rich Plasma (PRP) Market Trends and Forecast
3.3: Global Platelet Rich Plasma Market by Product
3.3.1: Pure PRP
3.3.2: Leukocyte-Rich PRP
3.3.3: Leukocyte-Rich Fibrin PRP
3.4: Global Platelet Rich Plasma Market by Origin
3.4.1: Autologous PRP
3.4.2: Allogeneic PRP
3.4.3: Homologous PRP
3.5: Global Platelet Rich Plasma Market by Application
3.5.1: Orthopedics
3.5.2: Cosmetic Surgery and Dermatology
3.5.3: Ophthalmic Surgery
3.5.4: Neurosurgery
3.5.5: General Surgery
3.5.6: Others
3.6: Global Platelet Rich Plasma Market by End User
3.6.1: Hospitals
3.6.2: Orthopedic Clinics
3.6.3: Dermatology Clinics
3.6.4: Others
4. MARKET TRENDS AND FORECAST ANALYSIS BY REGION
4.1: Global Platelet Rich Plasma Market by Region
4.2: North American Platelet Rich Plasma Market
4.2.1: Market by Product: Pure PRP, Leukocyte-Rich PRP, and Leukocyte-Rich Fibrin PRP
4.2.2: Market by Origin: Autologous PRP, Allogeneic PRP, and Homologous PRP
4.2.3: Market by Application: Orthopedics, Cosmetic Surgery and Dermatology, Ophthalmic Surgery, Neurosurgery, General Surgery, and Others
4.2.4: Market by End User: Hospitals, Orthopedic Clinics, Dermatology Clinics, and Others
4.2.5: The United States Platelet Rich Plasma Market
4.2.6: The Canadian Platelet Rich Plasma Market
4.2.7: The Mexican Platelet Rich Plasma Market
4.3: European Platelet Rich Plasma Market
4.3.1: Market by Product: Pure PRP, Leukocyte-Rich PRP, and Leukocyte-Rich Fibrin PRP
4.3.2: Market by Autologous PRP, Allogeneic PRP, and Homologous PRP
4.3.3: Market by Application: Orthopedics, Cosmetic Surgery and Dermatology, Ophthalmic Surgery, Neurosurgery, General Surgery, and Others
4.3.3: Market by End User: Hospitals, Orthopedic Clinics, Dermatology Clinics, and Others
4.3.4: The Platelet Rich Plasma Market of United Kingdom
4.3.5: The Spanish Platelet Rich Plasma Market
4.3.6: The German Platelet Rich Plasma Market
4.3.7: The French Platelet Rich Plasma Market
4.4: APAC Platelet Rich Plasma Market
4.4.1: Market by Product: Pure PRP, Leukocyte-Rich PRP, and Leukocyte-Rich Fibrin PRP
4.4.2: Market by Autologous PRP, Allogeneic PRP, and Homologous PRP
4.4.3: Market by Application: Orthopedics, Cosmetic Surgery and Dermatology, Ophthalmic Surgery, Neurosurgery, General Surgery, and Others
4.4.4: Market by End User: Hospitals, Orthopedic Clinics, Dermatology Clinics, and Others
4.4.5: The Chinese Platelet Rich Plasma Market
4.4.6: The Indian Platelet Rich Plasma Market
4.4.7: The Japanese Platelet Rich Plasma Market
4.5: ROW Platelet Rich Plasma Market
4.5.1: Market by Product: Pure PRP, Leukocyte-Rich PRP, and Leukocyte-Rich Fibrin PRP
4.5.2: Market by Autologous PRP, Allogeneic PRP, and Homologous PRP
4.5.3: Market by Application: Orthopedics, Cosmetic Surgery and Dermatology, Ophthalmic Surgery, Neurosurgery, General Surgery, and Others
4.5.4: Market by End User: Hospitals, Orthopedic Clinics, Dermatology Clinics, and Others
4.5.5: Brazilian Platelet Rich Plasma Market
5. COMPETITOR ANALYSIS
5.1: Market Share Analysis
5.2: Product Portfoli Analysis
5.3: Operational Integration
5.4: Geographical Reach
5.5: Porter’s Five Forces Analysis
6. COST STRUCTURE ANALYSIS
6.1: Cost of Goods Sold
6.2: SG&A
6.3: EBITDA Margin
7. GROWTH OPPORTUNITIES AND STRATEGIC ANALYSIS
7.1: Growth Opportunity Analysis
7.1.1: Growth Opportunities for the Global Platelet Rich Plasma Market by Product
7.1.2: Growth Opportunities for the Global Platelet Rich Plasma Market by Origin
7.1.3: Growth Opportunities for the Global Platelet Rich Plasma Market by Application
7.1.4: Growth Opportunities for the Global Platelet Rich Plasma Market by End User
7.1.5: Growth Opportunities for the Global Platelet Rich Plasma Market by Region
7.2: Emerging Trends in the Global Platelet Rich Plasma Market
7.3: Strategic Analysis
7.3.1: New Product Development
7.3.2: Capacity Expansion of the Global Platelet Rich Plasma Market
7.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Platelet Rich Plasma Market
7.3.4: Certification and Licensing
8. COMPANY PROFILES OF LEADING PLAYERS
8.1: Arthrex, Inc.
8.2: Terum BCT, Inc.
8.3: EmCyte Corporation
8.4: DePuy Synthes
8.5: Zimmer Biomet
8.6: Stryker
8.7: Glofinn Oy
8.8: DR. PRP America, LLC
8.9: Harvest Technologies Corporation
8.10: Adistem Ltd.
